Development and evaluation of a monolithic drug-in-adhesive patch for valsartan

International Journal of Pharmaceutics

Volumn 402, Issue 1-2, 2010, Pages 103-109

  Nishida, Naohiro ^a   Taniyama, Kazuhiro ^a   Sawabe, Toshihiro ^a   Manome, Yoichi ^a  

^a TOA EIYO LTD   (Japan)

Author keywords

Diisooctyl sodium sulfosuccinate; Drug in adhesive patch; Transdermal; Valsartan; Yucatan micro pig

Indexed keywords

DIISOOCTYL SODIUM SULFOSUCCINATE; MYRISTIC ACID ISOPROPYL ESTER; PENETRATION ENHANCING AGENT; UNCLASSIFIED DRUG; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG PENETRATION; FEASIBILITY STUDY; FEMALE; HAIRLESS MOUSE; HAIRLESS RAT; HUMAN; MALE; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SWINE; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; DIOCTYL SULFOSUCCINIC ACID; EXCIPIENTS; FEMALE; HUMANS; MALE; MICE; MICE, HAIRLESS; MYRISTATES; PERMEABILITY; RATS; RATS, HAIRLESS; SKIN ABSORPTION; SPECIES SPECIFICITY; SWINE; SWINE, MINIATURE; TETRAZOLES; TRANSDERMAL PATCH; VALINE;

EID: 78349306002     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.09.031     Document Type: Article

References (33)

1. Agrawala P., Ritschel W.A. Influence of 1-dodecylhexahydro-2H-azepin-2-one (Azone) on the in vitro permeation of verapamil hydrochloride across rat, hairless mouse, and human cadaver skin. J. Pharm. Sci. 1988, 77:776-778.
2. Benson H.A. Transdermal drug delivery: penetration enhancement techniques. Curr. Drug Deliv. 2005, 2:23-33.
3. Bronaugh R.L., Stewart R.F., Congdon E.R., Giles A.L. Methods for in vitro percutaneous absorption studies. I. Comparison with in vivo results. Toxicol. Appl. Pharmacol. 1982, 62:474-480.
4. Brookman L.J., Rolan P.E., Benjamin I.S., Palmer K.R., Wyld P.J., Lloyd P., Flesch G., Waldmeier F., Sioufi A., Mullins F. Pharmacokinetics of valsartan in patients with liver disease. Clin. Pharmacol. Ther. 1997, 62:272-278.
5. Cho Y.J., Choi H.K. Enhancement of percutaneous absorption of ketoprofen: effect of vehicles and adhesive matrix. Int. J. Pharm. 1998, 169:95-104.
6. Cyong J.C., Uebara K. Phase I study of angiotensin II receptor antagonist. CGP 48933 (Valsartan) - Single administration study 1998, vol. 14. pp. 1703-1725.
7. Diez I., Colom H., Moreno J., Obach R., Peraire C., Domenech J. A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists. J. Pharm. Sci. 1991, 80:931-934.
8. Flynn G.L., Durrheim H., Higuchi W.I. Permeation of hairless mouse skin II: membrane sectioning techniques and influence on alkanol permeabilities. J. Pharm. Sci. 1981, 70:52-56.
9. Fujii M., Yamanouchi S., Hori N., Iwanaga N., Kawaguchi N., Matsumoto M. Evaluation of Yucatan micropig skin for use as an in vitro model for skin permeation study. Biol. Pharm. Bull. 1997, 20:249-254.
10. Ghosh B., Reddy L.H., Kulkarni R.V., Khanam J. Comparison of skin permeability of drugs in mice and human cadaver skin. Indian J. Exp. Biol. 2000, 38:42-45.
11. Godin B., Touitou E. Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models. Adv. Drug Deliv. Rev. 2007, 59:1152-1161.
12. Gupta R.R., Jain S.K., Varshney M. AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil. Colloids Surf. B: Biointerfaces 2005, 41:25-32.
13. Higuchi T. Physical chemical analysis of percutaneous absorption process from creams and ointments. J. Soc. Cosmet. Chem. 1960, 11:85-97.
14. Israili Z.H. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension. J. Hum. Hypertens. 2000, 14:S73-S86.
15. Liron Z., Cohen S. Percutaneous absorption of alkanoic acids II: application of regular solution theory. J. Pharm. Sci. 1984, 73:538-542.
16. Loo J.C., Riegelman S. New method for calculating the intrinsic absorption rate of drugs. J. Pharm. Sci. 1968, 57:918-928.
17. Murthy S.N., Vishwanath B.A. N-octyl-beta-thioglucoside enhances the transdermal permeation of ketotifen. Pharmazie 2006, 61:75-76.
18. Myoung Y., Choi H.K. Effects of vehicles and pressure sensitive adhesives on the penetration of isosorbide dinitrate across the hairless mouse skin. Drug Deliv. 2002, 9:121-126.
19. Ngawhirunpat T., Opanasopit P., Prakongpan S. Comparison of skin transport and metabolism of ethyl nicotinate in various species. Eur. J. Pharm. Biopharm. 2004, 58:645-651.
20. Ogiso T., Iwaki M., Yoneda I., Horinouchi M., Yamashita K. Percutaneous absorption of elcatonin and hypocalcemic effect in rat. Chem. Pharm. Bull. (Tokyo) 1991, 39:449-453.
21. Ogiso T., Paku T., Iwaki M., Tanino T. Mechanism of the enhancement effect of n-octyl-beta-d-thioglucoside on the transdermal penetration of fluorescein isothiocyanate-labeled dextrans and the molecular weight dependence of water-soluble penetrants through stripped skin. J. Pharm. Sci. 1994, 83:1676-1681.
22. Ogiso T., Paku T., Iwaki M., Tanino T., Nishioka S. Percutaneous absorption of physiologically active peptides, ebiratide and elcatonin, in rats. Biol. Pharm. Bull. 1994, 17:1094-1100.
23. Panigrahi L., Ghosal S.K., Pattnaik S. Effect of permeation enhancers on the release and permeation kinetics of Lincomycin hydrochloride gel formulations through mouse skin. Indian J. Pharm. Sci. 2006, 68:205-211.
24. Panigrahi L., Pattnaik S., Ghosal S.K. The effect of pH and organic ester penetration enhancers on skin permeation kinetics of terbutaline sulfate from pseudolatex-type transdermal delivery systems through mouse and human cadaver skins. AAPS PharmSciTech 2005, 6:E167-E173.
25. Ren C., Fang L., Ling L., Wang Q., Liu S., Zhao L., He Z. Design and in vivo evaluation of an indapamide transdermal patch. Int. J. Pharm. 2009, 370:129-135.
26. Rizwan M., Aqil M., Ahad A., Sultana Y., Ali M.M. Transdermal delivery of valsartan: I. Effect of various terpenes. Drug Dev. Ind. Pharm. 2008, 34:618-626.
27. Roy S.D., Hou S.Y., Witham S.L., Flynn G.L. Transdermal delivery of narcotic analgesics: comparative metabolism and permeability of human cadaver skin and hairless mouse skin. J. Pharm. Sci. 1994, 83:1723-1728.
28. Scheuplein R.J. Mechanism of percutaneous absorption. J. Invest. Dermatol. 1967, 48:79-88.
29. Scott R.C., Walker M., Dugard P.H. A comparison of the in vitro permeability properties of human and some laboratory animal skins. Int. J. Cosmet. Sci. 1986, 8:189-194.
30. Sloan K.B., Koch S.A., Siver K.G., Flowers F.P. Use of solubility parameters of drug and vehicle to predict flux through skin. J. Invest. Dermatol. 1986, 87:244-252.
31. Sun Y., Fang L., Zhu M., Li W., Meng P., Li L., He Z. A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization. Int. J. Pharm. 2009, 382:165-171.
32. Varshney M., Khanna T., Changez M. Effects of AOT micellar systems on the transdermal permeation of glyceryl trinitrate. Colloids Surf. B: Biointerfaces 1999, 13:1-11.
33. Walker R.B., Smith E.W. The role of percutaneous penetration enhancers. Adv. Drug Deliv. Rev. 1996, 18:295-301.